Preview Mode Links will not work in preview mode

 

Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show is a window into the latest innovations in digital health and the changing dynamic between doctors and patients.

Topics on the show include

  • the emergence of personalized medicine and breakthroughs in genomics
  • advances in biopharmaceuticals
  • age related diseases and aging in place
  • using big data from wearables and sensors
  • transparency in the medical marketplace
  • challenges for connected health entrepreneurs

The audience includes researchers, medical professionals, patient advocates, entrepreneurs, patients, caregivers, solution providers, students, journalists, and investors.

Jan 17, 2022

Dr. Joseph O'Donnell is the Chief Medical Officer at Phosplatin Therapeutics founded to develop a drug with platinum in it to kill cancer cells. Phosplatin is in clinical trials with PT-112 which is the first cancer therapy molecule that has a pyrophosphate on it and works by harnessing the immune system and causing...


Jan 17, 2022

Dr. Joseph O'Donnell is the Chief Medical Officer at Phosplatin Therapeutics founded to develop a drug with platinum in it to kill cancer cells. Phosplatin is in clinical trials with PT-112 which is the first cancer therapy molecule that has a pyrophosphate on it and works by harnessing the immune system and causing...


Jan 6, 2022

Tzvia Bader is the CEO and Co-Founder of TrialJectory which is an Ai-powered tech platform that matches cancer patients with the right clinical trials for their exact diagnosis. TrialJectory also gives pharmaceutical companies and CROs access to patient insights to allow them to effectively design and recruit for...


Jan 6, 2022

Tzvia Bader is the CEO and Co-Founder of TrialJectory which is an Ai-powered tech platform that matches cancer patients with the right clinical trials for their exact diagnosis. TrialJectory also gives pharmaceutical companies and CROs access to patient insights to allow them to effectively design and recruit for...


Dec 30, 2021

Dr. Dan Gold is the President and CEO of MEI Pharma and is tackling non-Hodgkin's B cell lymphoma to bring a therapy to patients minimizing the toxicities that are associated with current treatments. Their drug candidate zandelisib is a P13K delta inhibitor. It is being studied in lymphoma in B cells to determine if...